Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
Authors
Keywords
Apoptosis, Hepatoma cells, Hepatocellular carcinoma, Transfection, Gene expression, MAPK signaling cascades, Cell proliferation, Small interfering RNAs
Journal
PLoS One
Volume 12, Issue 3, Pages e0174153
Publisher
Public Library of Science (PLoS)
Online
2017-03-22
DOI
10.1371/journal.pone.0174153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling
- (2016) Seulki Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- APASL consensus statements and recommendation on treatment of hepatitis C
- (2016) Masao Omata et al. Hepatology International
- C-Jun N-terminal kinase signalling pathway in response to cisplatin
- (2016) Dong Yan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
- (2016) Reina Sasaki et al. PLoS One
- Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
- (2016) Juan Wang et al. Targeted Oncology
- Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence
- (2016) Wei Chen et al. Scientific Reports
- Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver
- (2015) Reina Sasaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice
- (2015) C Trierweiler et al. CELL DEATH AND DIFFERENTIATION
- Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling
- (2015) Xin Yin et al. Journal of Hematology & Oncology
- Perspectives and control of hepatitis B virus infection in Taiwan
- (2015) Chih-Lin Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy
- (2015) R Mandal et al. ONCOGENE
- MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603
- (2015) Liza C. Villaruz et al. Clinical Epigenetics
- Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib
- (2014) Kai Mao et al. CANCER LETTERS
- Involvement of androgen receptor and glucose-regulated protein 78kDa in human hepatocarcinogenesis
- (2014) Xia Jiang et al. EXPERIMENTAL CELL RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
- (2013) Xiao-Yong Huang et al. HEPATOLOGY
- Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK
- (2013) H. Vin et al. MOLECULAR CANCER THERAPEUTICS
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
- (2012) Ann-Lii Cheng et al. EUROPEAN JOURNAL OF CANCER
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
- (2012) Tokuzo Arao et al. HEPATOLOGY
- Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
- (2012) Angela Gauthier et al. HEPATOLOGY RESEARCH
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Functional and Clinical Evidence of the Influence of Sorafenib Binding to Albumin on Sorafenib Disposition in Adult Cancer Patients
- (2011) Michel Tod et al. PHARMACEUTICAL RESEARCH
- Induction of DNA Damage-Inducible Gene GADD45 Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
- (2010) D.-L. Ou et al. CANCER RESEARCH
- A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer
- (2010) J. S. W. Lind et al. CLINICAL CANCER RESEARCH
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Molecular targeted therapy for hepatocellular carcinoma
- (2009) Melanie Thomas JOURNAL OF GASTROENTEROLOGY
- TRAIL-induced apoptosis of hepatocellular carcinoma cells isaugmented by targeted therapies
- (2009) Bruno Christian Koehler et al. WORLD JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started